misight 1 day omafilcon a soft hydrophilic contact lenses for daily wear

MiSight 1 Day is a soft hydrophilic contact lens made from omafilcon A, intended for daily wear. It is designed to control myopia progression in children by utilizing a dual-focus optical design.

MiSight 1 Day is commonly used in pediatric ophthalmology to manage myopia progression in children. It is particularly useful in cases where slowing the progression of myopia is clinically indicated.

The available literature includes 10 studies, comprising randomized clinical trials and prospective studies, conducted between 2020 and 2025. These studies collectively provide evidence on the efficacy and safety of MiSight 1 Day lenses.

Published studies report that MiSight 1 Day lenses effectively slow myopia progression in children over multiple years. A 3-year randomized clinical trial demonstrated significant reductions in myopia progression compared to control groups. Long-term studies indicate that treatment gains are retained even after cessation of lens use.

Reported complications include typical contact lens-related issues such as discomfort and mild irritation. Long-term studies have shown that MiSight 1 Day lenses are generally safe for pediatric use, with no significant adverse events reported over a 6-year period.

While the evidence supports the efficacy of MiSight 1 Day lenses, further research is needed to explore long-term outcomes beyond the cessation of treatment. Additionally, more studies are required to assess the device's effectiveness across diverse populations.